BlackRock Amends Axogen Stake, Updates Passive Investment
Ticker: AXGN · Form: SC 13G/A · Filed: Jan 26, 2024 · CIK: 805928
| Field | Detail |
|---|---|
| Company | Axogen, Inc. (AXGN) |
| Form Type | SC 13G/A |
| Filed Date | Jan 26, 2024 |
| Risk Level | low |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amendment, passive-investment
TL;DR
**BlackRock updated its passive stake in Axogen, signaling a portfolio adjustment.**
AI Summary
BlackRock Inc. filed an amended Schedule 13G/A on January 26, 2024, indicating a change in its ownership stake in Axogen, Inc. as of December 31, 2023. This filing, Amendment No. 6, updates BlackRock's passive investment position in Axogen's Common Stock. For investors, this matters because BlackRock is a major institutional investor, and changes in its holdings can signal shifts in its confidence in Axogen's future performance, potentially influencing other investors' decisions.
Why It Matters
Changes in major institutional holdings like BlackRock's can influence market sentiment and stock price, as large investors often have significant research capabilities.
Risk Assessment
Risk Level: low — This filing is a routine update from a passive institutional investor and does not indicate any immediate or significant risk to the company or its shareholders.
Analyst Insight
Investors should note BlackRock's continued passive interest in Axogen, but this filing alone doesn't provide enough detail to warrant immediate action. Further investigation into the specific change in BlackRock's percentage ownership would be prudent.
Key Players & Entities
- BlackRock Inc. (company) — the institutional investor filing the SC 13G/A
- Axogen, Inc. (company) — the subject company whose securities are being reported
- December 31, 2023 (date) — the date of the event requiring the filing
- January 26, 2024 (date) — the filing date of the SC 13G/A
- Amendment No: 6 (number) — the specific amendment number of the filing
FAQ
What type of filing is this document?
This document is an SC 13G/A, which is an amendment to a Schedule 13G filing, as indicated by 'FORM TYPE: SC 13G/A' and 'SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 6)'.
Who is the filer of this SC 13G/A?
The filer of this SC 13G/A is BlackRock Inc., as stated under the 'FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: BlackRock Inc.' section.
Which company's securities are the subject of this filing?
The securities of Axogen, Inc. are the subject of this filing, as indicated by 'SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Axogen, Inc.' and 'AXOGEN, INC (Name of Issuer)'.
What was the date of the event that triggered this filing?
The date of the event which required the filing of this statement was December 31, 2023, as specified by 'December 31, 2023 (Date of Event Which Requires Filing of this Statement)'.
Under which rule is this Schedule 13G/A filed?
This Schedule 13G/A is filed under Rule 13d-1(b), as indicated by the checked box '[X] Rule 13d-1(b)'.
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on January 26, 2024 regarding Axogen, Inc. (AXGN).